On Sunday, Breitbart posted an article about a bill that the West Virginia Senate passed on Friday.
The article reports:
State senators in West Virginia passed a bill on Friday that would outlaw sending abortion pills into the state.
Lawmakers approved Senate Bill 173 with a vote of 31 to 1 and two members absent, West Virginia Watch reported.
West Virginia has a near-total abortion restriction and also bans abortion via telemedicine. Senate Bill 173 is designed to close a loophole in state law enabling out-of-state organizations and abortionists to mail abortion pills to people in the state.
The bill’s lead sponsor, state Sen. Chris Rose (R), said the bill would show “bad actors” that West Virginia will not tolerate those who shirk the state’s laws protecting unborn babies, according to the report.
“We will fight from the womb to the tomb to preserve every human being,” Rose said. “And we will defend the constitutional rights of life, liberty and the pursuit of happiness even for the unborn.”
Under the bill, non-medical professionals could face three to ten years behind bars for the felony charge of sending abortion drugs by mail to a person in West Virginia. A medical professional who does so would face losing their license, according to the report.
The bill contains an exception for physicians who prescribe the drugs for other legitimate medical reasons besides abortion, per the report.
Lawmakers approved at least two amendments to the bill, including one from state Sen. Eric Tarr (R) that would require the state attorney general’s office to report how many lawsuits are filed on behalf of women who use the abortion drugs.
The bill now goes to the House of Delegates.
The danger of obtaining mifepristone, the abortion drug, through the mail is that the drug can have complications if used for abortion. If there is not a doctor on site supervising, using the drug could be fatal.
According to PubMed:
Methods: Adverse Event Reports (AERs) for mifepristone used as an abortifacient, submitted to the FDA from September 2000 to February 2019, were analyzed using the National Cancer Institute’s Common Terminology Criteria for Adverse Events (CTCAEv3).
Results: The FDA provided 6158 pages of AERs. Duplicates, non-US, or AERs previously published (Gary, 2006) were excluded. Of the remaining, there were 3197 unique, US-only AERs of which there were 537 (16.80%) with insufficient information to determine clinical severity, leaving 2660 (83.20%) Codable US AERs. (Figure 1). Of these, 20 were Deaths, 529 were Life-threatening, 1957 were Severe, 151 were Moderate, and 3 were Mild.
The deaths included: 9 (45.00%) sepsis, 4 (20.00%) drug toxicity/overdose, 1 (5.00%) ruptured ectopic pregnancy, 1 (5.00%) hemorrhage, 3 (15.00%) possible homicides, 1 (5.00%) suicide, 1 (5.00%) unknown. (Table 1).
Retained products of conception and hemorrhage caused most morbidity. There were 75 ectopic pregnancies, including 26 ruptured ectopics (includes one death).
There were 2243 surgeries including 2146 (95.68%) D&Cs of which only 853 (39.75%) were performed by abortion providers.
Of 452 patients with ongoing pregnancies, 102 (22.57%) chose to keep their baby, 148 (32.74%) had terminations, 1 (0.22%) miscarried, and 201 (44.47%) had unknown outcomes.
Hemorrhage occurred more often in those who took mifepristone and misoprostol (51.44%) than in those who took mifepristone alone (22.41%).
Conclusions: Significant morbidity and mortality have occurred following the use of mifepristone as an abortifacient. A pre-abortion ultrasound should be required to rule out ectopic pregnancy and confirm gestational age. The FDA AER system is inadequate and significantly underestimates the adverse events from mifepristone.
Ending a baby’s life is not an acceptable practice, and with mifepristone, it could end your life as well.